Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Mechanism-guided quantification of LINE-1 reveals p53 regulation of both retrotransposition and transcription

Alexander Solovyov, Julie M. Behr, David Hoyos, Eric Banks, Alexander W. Drong, Jimmy Z. Zhong, Enrique Garcia-Rivera, Wilson McKerrow, Chong Chu, Dennis M. Zaller, Menachem Fromer, Benjamin D. Greenbaum
doi: https://doi.org/10.1101/2023.05.11.539471
Alexander Solovyov
1Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie M. Behr
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Hoyos
1Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Banks
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander W. Drong
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jimmy Z. Zhong
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrique Garcia-Rivera
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilson McKerrow
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chong Chu
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis M. Zaller
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Menachem Fromer
2ROME Therapeutics, Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin D. Greenbaum
1Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
3Physiology, Biophysics & Systems Biology, Weill Cornell Medical College, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: greenbab@mskcc.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Somatic activity of LINE-1 (L1) mobile elements has been implicated in cancer etiology, which may be related to the loss of p53-mediated regulation as a result of TP53 mutations. Quantifying the mechanisms of L1 regulation in cancer has been challenging. Here, we build a statistical model of L1 regulation by simultaneously quantifying L1 retrotransposition, L1 expression, and the fitness costs of mutated TP53 with precision. We first developed Total ReCall, an algorithm specifically tailored to the mechanisms of L1 reintegration, to detect L1 insertions from short-read whole-genome sequencing. Applying Total ReCall to high-quality data consisting of >750 paired tumor and normal samples from The Cancer Genome Atlas (TCGA) shows high L1 insertion heterogeneity among tumor types, with increased retrotransposition burden in lung squamous cell carcinoma, head and neck, and colon cancers. We next assessed the active RNA expression of intact L1 in >9,000 TCGA tumor samples, establishing, for the first time, a clear correlation between L1 expression and retrotransposition. Finally, we integrated the number of L1 insertions, L1 expression and a mathematical model of TP53 fitness into a multi-modal model of p53- mediated mechanisms of L1 regulation. We show that TP53 mutations enable retrotransposition both by disinhibiting L1 expression and enabling its reintegration and quantify the relative weights of this dual regulatory role. We demonstrate how mechanism-based multi-modal modeling applied at scale can statistically disentangle the complex interplay between canonical driver events in tumor evolution and retrotransposon activity.

Competing Interest Statement

At the time of the work, JMB, AWD, JZZ, EGR, WM, CC, DMZ, and MF were full-time employees of, and hold stock options of, ROME Therapeutics. BDG is a scientific co-founder of, consults for, and holds stock options of ROME Therapeutics. AS has done consulting work for PMV Pharma and ROME Therapeutics; he holds stock options of ROME Therapeutics. EB is a full-time employee of The Broad Institute.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 12, 2023.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Mechanism-guided quantification of LINE-1 reveals p53 regulation of both retrotransposition and transcription
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mechanism-guided quantification of LINE-1 reveals p53 regulation of both retrotransposition and transcription
Alexander Solovyov, Julie M. Behr, David Hoyos, Eric Banks, Alexander W. Drong, Jimmy Z. Zhong, Enrique Garcia-Rivera, Wilson McKerrow, Chong Chu, Dennis M. Zaller, Menachem Fromer, Benjamin D. Greenbaum
bioRxiv 2023.05.11.539471; doi: https://doi.org/10.1101/2023.05.11.539471
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Mechanism-guided quantification of LINE-1 reveals p53 regulation of both retrotransposition and transcription
Alexander Solovyov, Julie M. Behr, David Hoyos, Eric Banks, Alexander W. Drong, Jimmy Z. Zhong, Enrique Garcia-Rivera, Wilson McKerrow, Chong Chu, Dennis M. Zaller, Menachem Fromer, Benjamin D. Greenbaum
bioRxiv 2023.05.11.539471; doi: https://doi.org/10.1101/2023.05.11.539471

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4383)
  • Biochemistry (9602)
  • Bioengineering (7097)
  • Bioinformatics (24869)
  • Biophysics (12623)
  • Cancer Biology (9961)
  • Cell Biology (14359)
  • Clinical Trials (138)
  • Developmental Biology (7960)
  • Ecology (12111)
  • Epidemiology (2067)
  • Evolutionary Biology (15990)
  • Genetics (10929)
  • Genomics (14745)
  • Immunology (9871)
  • Microbiology (23680)
  • Molecular Biology (9486)
  • Neuroscience (50887)
  • Paleontology (369)
  • Pathology (1540)
  • Pharmacology and Toxicology (2683)
  • Physiology (4019)
  • Plant Biology (8657)
  • Scientific Communication and Education (1510)
  • Synthetic Biology (2397)
  • Systems Biology (6440)
  • Zoology (1346)